𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Absence of Severe Systemic Toxicity After Leakage-Controlled Isolated Limb Perfusion With Tumor Necrosis Factor-α and Melphalan

✍ Scribed by Bart C. Vrouenraets; Bin B. R. Kroon; Aernout C. Ogilvie; Albert N. van Geel; Omgo E. Nieweg; Anton J. G. Swaak; Alexander M. M. Eggermont

Publisher
Springer
Year
1999
Tongue
English
Weight
94 KB
Volume
6
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isolated limb reperfusion with tumor nec
Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics
✍ David L. Bartlett; Grace Ma; H. Richard Alexander; Steven K. Libutti; Douglas L. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

## Background: This retrospective study evaluated the benefit of using tumor necrosis factor (tnf) and melphalan administered via an isolated limb perfusion (ilp) in a series of patients with metastatic melanoma who failed initial ilp with chemotherapeutics. ## Methods: Seventeen patients with ex

Isolated limb perfusion with tumor necro
Isolated limb perfusion with tumor necrosis factor-α and melphalan for patients with unresectable soft tissue sarcoma of the extremities
✍ Eva M. Noorda; Bart C. Vrouenraets; Omgo E. Nieweg; Frits van Coevorden; Gooike 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## BACKGROUND Since 1992, isolated limb perfusion (ILP) with tumor necrosis factor‐α (TNFα) and melphalan has been used for the treatment of patients with unresectable soft tissue sarcomas of the extremities. The authors retrospectively studied the results of limb salvage surgery using